BioSpace News Archive

Pictured: 3D illustration of stem cells used for cell therapy

IN PARTNERSHIP WITH LONGEVITY MEDICAL INSTITUTE

Regenerative medicine needs more than stem cells

Stem cell therapies vary widely yet many physicians still treat them as interchangeable. A more credible model requires diagnostics, product characterization and conventional medical context to determine who and when should receive regenerative treatment.

September 28, 2026

·

4 min read

·

Jennifer C. Smith-Parker

Employer Resources

Report: What Powers Employee Engagement

What drives meaningful employee engagement in today’s life sciences workplace? This BioSpace report explores the factors that shape how employees feel about their organizations and what employers can do to create workplaces where talent wants to stay and thrive.

September 28, 2026

·

1 min read

·

BioSpace Insights

Business concept vector illustration of a businessman climbing a ladder to reach out for the stars

Immunology and inflammation

6 immunology targets to sustain a mammoth I&I market

Johnson & Johnson, Pfizer, Argenx and more are unlocking new immunology targets and looking to improve on existing ones in an attempt to catch some of the magic brought about by AbbVie’s Humira and Sanofi and Regeneron’s Dupixent.

September 28, 2026

·

8 min read

·

Tristan Manalac

change business strategy to achieve business goals or target, recovering from the economic crisis, businessman jumps from the red graph down to the green growing graph concept vector illustration

Rare diseases

Milestone Sanfilippo nod helps Ultragenyx regroup after tough Angelman defeat

The recent FDA approval of Fayuvi for a rare, childhood neurodegenerative disease was “particularly special” for Ultragenyx CEO Emil Kakkis. It could also, along with an August nod for another gene therapy, help offset recent challenges brought on by two asset failures.

September 28, 2026

·

5 min read

·

Heather McKenzie

Press Releases

Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn

September 28, 2026

·

8 min read

Press Releases

ASTRO 2026 Presentations Demonstrate Role of Genetics in Predicting Adverse Events and Response From Radiation Treatment